Galsulfase Side Effects
Medically reviewed by Drugs.com. Last updated on Jun 9, 2024.
Applies to galsulfase: intravenous solution.
Precautions
If you will be using this medicine for a long time, it is very important that your doctor check you or your child at regular visits for any problems or unwanted effects that may be caused by this medicine.
This medicine may cause serious types of allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Tell your doctor or nurse right away if you have dizziness, lightheadedness, a rash, itching, hoarseness, trouble breathing or swallowing, or any swelling of your hands, face, or mouth while you or your child are using this medicine.
This medicine may cause headaches and skin reactions, such as a rash or itching, while you are receiving the injection or within 24 hours after you receive it. Check with your doctor or nurse right away if you or your child have any of these symptoms.
This medicine can cause fever and allergic-type reactions. You or your child will receive medicines to prevent these side effects, and that medicine may make you drowsy. Avoid driving, using machines, or doing anything else that could be dangerous if you are not alert.
Tell your doctor right away if you have back pain, paralysis of the limbs, or loss of bladder or bowel control after receiving this medicine. These could be symptoms of a condition called spinal or cervical cord compression (SCC).
Your doctor may want you or your child to join a patient registry for patients using this medicine. This will help you monitor the progress of your disease while on long-term treatment using this medicine.
Common side effects of galsulfase
Some side effects of galsulfase may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- diarrhea
- ear pain
- loss of appetite
Less common side effects
- body aches or pain
- burning, dry, or itching eyes
- congestion
- dryness or soreness of the throat
- excessive tearing
- loss of or increase in reflexes
- runny or stuffy nose
- tender, swollen glands in the neck
- trouble with swallowing
- unusual tiredness or weakness
- voice changes
Incidence not known
- difficulty with moving
- loss of voice
- muscle pain or stiffness
- sneezing
Serious side effects of galsulfase
Along with its needed effects, galsulfase may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking galsulfase:
Less common side effects
- blurred or decreased vision
- chest pain
- difficult or labored breathing
- dizziness
- headache
- hernia of the naval
- nervousness
- pounding in the ears
- slow or fast heartbeat
- swelling of the face
- tightness in the chest
Incidence not known
- back pain
- bluish lips or skin
- confusion
- cough
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- fever, chills, or sweating
- hives or welts
- joint pain
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- loss of bladder control
- loss of bowel control
- nausea or vomiting
- paralysis of the limbs
- stomach pain
For healthcare professionals
Applies to galsulfase: intravenous solution.
General adverse events
The most frequently reported adverse reactions included rash, pain, urticaria, pyrexia, pruritus, chills, headache, nausea, vomiting, abdominal pain, and dyspnea.
The most frequently reported adverse reactions requiring interventions are infusion-related reactions.[Ref]
Hypersensitivity
- Frequency not reported: Anaphylaxis/anaphylactoid reaction, allergic reaction[Ref]
Dermatologic
- Very common (10% or more): Rash (21%), angioedema, urticaria, pruritus
- Common (1% to 10%): Erythema[Ref]
Gastrointestinal
- Very common (10% or more): Abdominal pain (47%), gastroenteritis (11%), umbilical hernia (11%), nausea, vomiting[Ref]
Other
- Very common (10% or more): Infusion reactions (56%), ear pain (42%), pain (32%), chills/rigors (21%), chest pain (16%), malaise (11%), hearing impairment (11%), pyrexia[Ref]
Infusion reactions, which occurred in 56% of patients across 5 clinical studies were defined as adverse reactions occurring during infusions or until the end of the infusion day. Infusion reactions were observed as early as week 1 and as late as week 146 of treatment and occurred during multiple infusions, however, not always in consecutive weeks. The most common signs/symptoms included pruritus, vomiting, abdominal pain, nausea, hypertension, headache, chest pain, erythema, cough, hypotension, angioedema, respiratory distress, tremor, conjunctivitis, malaise, bronchospasm, and arthralgia.[Ref]
Cardiovascular
- Very common (10% or more): Hypertension (11%)
- Common (1% to 10%): Hypotension
- Frequency not reported: Pallor, bradycardia, tachycardia, cyanosis, shock[Ref]
Nervous system
- Very common (10% or more): Areflexia (11%), headache
- Common (1% to 10%): Tremor
- Frequency not reported: Paresthesia[Ref]
Respiratory
- Very common (10% or more): Dyspnea (21%), pharyngitis (11%), nasal congestion (11%)
- Common (1% to 10%): Apnea, cough, respiratory distress, asthma, bronchospasm
- Frequency not reported: Laryngeal edema, hypoxia, tachypnea, sleep apnea
- Postmarketing reports: Respiratory failure[Ref]
Musculoskeletal
- Very common (10% or more): Arthralgia (42%)[Ref]
Ocular
- Very common (10% or more): Conjunctivitis (21%), corneal opacity (11%)[Ref]
Immunologic
- Very common (10% or more): Development of antidrug antibodies (98%)[Ref]
During clinical trials, 53 out of 54 patients tested positive for antidrug IgG antibodies within 4 to 8 weeks of treatment. In the placebo controlled study, 19 patients were evaluated for a potential relationship between development of antidrug antibodies to clinical outcome measures. While all 19 patients developed antidrug antibodies, there was no consistent predictive relationship between total antibody titer, neutralizing or IgE antibodies, and infusion-associated reactions, urinary glycosaminoglycan (GAG) levels, or endurance measures.[Ref]
Renal
- Postmarketing reports: Membranous nephropathy[Ref]
Hematologic
- Postmarketing reports: Thrombocytopenia[Ref]
See also:
Naglazyme
Naglazyme is used to treat patients with mucopolysaccharidosis type VI. Learn about side effects ...
Aldurazyme
Aldurazyme is used to treat the symptoms of Hurler syndrome. Learn about side effects, interactions ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Brineura
Brineura (cerliponase alfa) is used to slow the loss of ability to crawl or walk in children and ...
Cerezyme
Cerezyme is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme ...
Elaprase
Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called ...
Elelyso
Elelyso (taliglucerase alfa) is used to treat Gaucher disease. Includes Elelyso side effects ...
Elfabrio
Elfabrio (pegunigalsidase alfa-iwxj) is an enzyme replacement treatment that may be used long-term ...
Fabrazyme
Fabrazyme (agalsidase beta) is used in the treatment of Fabry disease. Includes Fabrazyme side ...
References
1. (2005) "Product Information. Naglazyme (galsulfase)." BioMarin Pharmaceutical Inc
2. EMEA. European Medicines Agency (2007) EPARs. European Union Public Assessment Reports. http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/medicines/medicines_landingpage.jsp&mid
3. Cerner Multum, Inc. "Australian Product Information."
More about galsulfase
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Galsulfase side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.